DIAPH3 is a prognostic biomarker and inhibit colorectal cancer progression through maintaining EGFR degradation.
Renli HuangCheng WuJialing WenJianyang YuHuidong ZhuJinlong YuZhaowei ZouPublished in: Cancer medicine (2022)
ACGs play a significant role in tumor invasion and have the potential to predict the prognosis of CRC. Prognosis-related ACGs DIAPH3 might be a new prognostic biomarker and DIAPH3 could inhibit CRC progression through maintaining EGFR degradation.